Supplementary Figure S7 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer

2026 Open access

Read full text
Authors: Marco Avolio, Simonetta Maria Leto, Francesco Paolo Sassi, Barbara Lupo, Elena Grassi, Irene Catalano, Eugenia Rosalinda Zanella, Valentina Vurchio, Francesca Cottino, Petros K. Tsantoulis, Luca Lazzari, Paolo Luraghi
+25 more Martina Ferri, Francesco Galimi, Enrico Berrino, Sara E. Bellomo, Marco Viviani, Alberto Sogari, Gianluca Mauri, Federica Tosi, Federica Cruciani, Andrea Sartore Bianchi, Salvatore Siena, Felice Borghi, Valter Torri, Elena Élez, Josep M. Tabernero, Maria Nieva, Clara O. Montagut, Noelia Tarazona, Andrès M.R. Cervantes, Sabine Tejpar, Alberto Bardelli, Caterina Marchiò, Silvia Marsoni, Andrea Bertotti, Livio Trusolino
DOI: 10.1158/2159-8290.31276760
Cited by: 0

Abstract

RAD51 as a biomarker of FOLFIRI resistance in PDXs and tumoroids

Fields of Study & Subjects

Colorectal Cancer Treatments and Studies Genetic factors in colorectal cancer Cancer therapeutics and mechanisms

Publication details

Publication date
6 February 2026